Objetivo
Traditional preclinical discovery methods, particularly for target validation, poorly predict drug efficacy, causing a high attrition rate in costly late-stage clinical trials. The PREDECT consortium will focus on complex but transferable, next generation in vitro and in vivo models for breast, prostate and lung cancers. Models will be investigated for their improved potential to validate novel therapeutic targets. Known targets, in canonical pathways, will be interrogated for induction of phenotypic, proteomic and transcriptomic changes using inhibitors. A strategy of seeking a ‘dynamic reciprocity’ of concordance between the steady and perturbed states of in vitro complex cultures, tissue slices and in vivo tumour models will be pursued by systems biology analyses. Comparison with historic gene expression and genomic data from relevant clinical materials should permit the emergence of faithful models for target validation and beyond.
PREDECT is coordinated by Servier and AstraZeneca, and the managing entity of IMI JU funding is the University of Helsinki. The team assembles world-class biologists, clinicians and computational scientists from 8 prestigious EU institutes, 3 SMEs and 8 EFPIA members to develop and critically assess models for target validation. The interaction between pharmaceutical and academic participants will be proactive, through postdoc co-supervision and work package co-piloting.
We propose to develop and generate a repository of advanced complex models in 3 complementary areas: (i) in vitro 2D/3D organotypic (co-)cultures, stirred bioreactor aggregates and tissue slice systems; (ii) novel (orthotopic) grafts of human and mouse tumour samples; and (iii) genetically-engineered and mosaic mouse models. The deliverables of PREDECT are expected to shift paradigms in target validation, permitting greater predictivity of drug efficacy in patient cohorts.
Ámbito científico
Convocatoria de propuestas
IMI-JU-02-2009
Consulte otros proyectos de esta convocatoria
Régimen de financiación
JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)Coordinador
91190 GIF-SUR-YVETTE
Francia
Ver en el mapa
Participantes (20)
00014 Helsingin Yliopisto
Ver en el mapa
La participación finalizó
02044 VTT ESPOO
Ver en el mapa
1015 Lausanne
Ver en el mapa
7610001 Rehovot
Ver en el mapa
2781-901 Oeiras
Ver en el mapa
6525 XZ Nijmegen
Ver en el mapa
3015 GD Rotterdam
Ver en el mapa
51005 Tartu
Ver en el mapa
79108 Freiburg
Ver en el mapa
00290 Helsinki
Ver en el mapa
151 85 Sodertaelje
Ver en el mapa
13353 Berlin
Ver en el mapa
02200 Espoo
Ver en el mapa
4070 Basel
Ver en el mapa
La participación finalizó
00144 Roma
Ver en el mapa
55218 Ingelheim
Ver en el mapa
70376 Stuttgart
Ver en el mapa
2340 Beerse
Ver en el mapa
CF24 0DE Cardiff
Ver en el mapa
60064 North Chicago Il
Ver en el mapa